Regenxbio (RGNX) Receivables - Net (2014 - 2025)

Regenxbio's Receivables - Net history runs 12 years deep, the most recent figure standing at $28.7 million for Q4 2025.

• In Q4 2025, Receivables - Net rose 36.97% year-over-year to $28.7 million; the TTM figure through Dec 2025 stood at $28.7 million (up 36.97% YoY), while the FY2025 annual figure was $28.7 million, up 36.97% from the prior year.
• Receivables - Net was $28.7 million for Q4 2025 at Regenxbio, up from $25.3 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $48.7 million in Q3 2021 to a low of $16.4 million in Q1 2024.
• Historically, Receivables - Net has averaged $29.2 million across 5 years, with a median of $27.1 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Receivables - Net sank 61.21% in 2021, then surged 36.97% in 2025.
• A 5-year view of Receivables - Net shows it stood at $34.7 million in 2021, then decreased by 14.74% to $29.6 million in 2022, then decreased by 13.84% to $25.5 million in 2023, then fell by 17.83% to $20.9 million in 2024, then soared by 36.97% to $28.7 million in 2025.
• The last three Receivables - Net figures came in at $28.7 million (Q4 2025), $25.3 million (Q3 2025), and $21.8 million (Q2 2025), per Business Quant data.